GI Cancer Immunotherapy Breakthroughs Signal New Era
Issued on behalf of Oncolytics Biotech Inc. Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal junction cancers last month,...